
Nepafenac (0.1% w/v)
Active composition
Nepafenac is converted to its active form in the eye, where it inhibits cyclooxygenase enzymes, reducing the synthesis of inflammatory mediators.
Medical applications
Nepaze Ophthalmic Suspension is a pharmaceutical formulation containing Nepafenac at a concentration of 0.1% (w/v). This suspension is designed for topical ocular administration in patients with inflammatory conditions associated with ocular surgery, such as posterior segment and anterior chamber procedures. Nepafenac, a non-steroidal anti-inflammatory drug (NSAID), acts by inhibiting cyclooxygenase (COX-1 and COX-2), thereby reducing inflammation, pain, and the risk of post-operative complications. The use of Nepaze Ophthalmic Suspension contributes to a faster recovery and improves the overall success rate of ocular surgical interventions. However, it is essential to follow the prescribed dosage and administer the drops carefully to ensure optimal therapeutic effects and minimize potential side effects.
Benzophenone Derivatives
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nepaze Ophthalmic Suspension may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of Nepaze Ophthalmic Suspension during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Nepaze Ophthalmic Suspension may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Nepaze Ophthalmic Suspension

Nepafenac (0.1% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Nepafenac is converted to its active form in the eye, where it inhibits cyclooxygenase enzymes, reducing the synthesis of inflammatory mediators.
Medical applications
Nepaze Ophthalmic Suspension is a pharmaceutical formulation containing Nepafenac at a concentration of 0.1% (w/v). This suspension is designed for topical ocular administration in patients with inflammatory conditions associated with ocular surgery, such as posterior segment and anterior chamber procedures. Nepafenac, a non-steroidal anti-inflammatory drug (NSAID), acts by inhibiting cyclooxygenase (COX-1 and COX-2), thereby reducing inflammation, pain, and the risk of post-operative complications. The use of Nepaze Ophthalmic Suspension contributes to a faster recovery and improves the overall success rate of ocular surgical interventions. However, it is essential to follow the prescribed dosage and administer the drops carefully to ensure optimal therapeutic effects and minimize potential side effects.
Benzophenone Derivatives
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nepaze Ophthalmic Suspension may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of Nepaze Ophthalmic Suspension during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Nepaze Ophthalmic Suspension may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Nepaze Ophthalmic Suspension















